Expression and Prognostic Value of the Lung Resistance-related Protein (LRP) in Germ Cell Testicular Tumors

László Mándoky, L. Géczi, Zoltán Doleschall, I. Bodrogi, O. Csuka, M. Kásler, M. Bak

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Lung resistance-related protein (LRP) was first detected in a non-P-glycoprotein-mediated multidrug-resistant lung cancer cell line and has been shown to be the major human vault protein. The aim of this study was to evaluate the expression of LRP in germ cell testicular tumors (GCT) and to determine the correlation between LRP expression and the clinical outcome of these tumors. Patients and Methods: Seventy cases of primary testicular tumors were investigated. LRP protein was detected by immunohistochemistry and Western blotting methods. LRP mRNA was determined with RT-PCR. Patients' clinical parameters and tumor response to treatment were recorded. Results: With immunohistochemistry, LRP was detected in 29 (41%) out of 70 primary testicular tumors. Twenty-two (63%) out of 35 tumors expressed LRP mRNA and LRP protein on examination by RT-PCR and Western blotting, respectively. Pure teratomas showed significantly higher LRP expression compared to other types of GCTs (p=0.0418). No relationship was demonstrated between the LRP immunostaining and stage of disease (p=0.2263). A significantly higher proportion of patients with LRP-negative tumors achieved complete response than those with LRP-positive tumors (p=0.0155). Patients whose tumors showed expression of LRP had significantly shorter overall survival (p=0.0428) than LRP-negative patients. Conclusion: Immunohistochemistry is a reliable method to evaluate LRP expression in testicular germ cell tumors. A positive correlation was found between LRP immunostaining and pure teratomas. LRP expression was associated with an adverse clinical outcome and shorter overall survival. Our findings suggest that LRP has prognostic value in testicular germ cell tumors and can predict clinical outcome.

Original languageEnglish
Pages (from-to)1097-1104
Number of pages8
JournalAnticancer Research
Volume24
Issue number2 C
Publication statusPublished - Mar 2004

Fingerprint

Testicular Germ Cell Tumor
major vault protein
Neoplasms
Immunohistochemistry
Teratoma
Testicular Neoplasms
Western Blotting
Polymerase Chain Reaction
Messenger RNA
Survival
Lung Neoplasms
Glycoproteins
Proteins
Cell Line
Therapeutics

Keywords

  • Lung resistance-related protein
  • Testicular germ cell tumor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Expression and Prognostic Value of the Lung Resistance-related Protein (LRP) in Germ Cell Testicular Tumors. / Mándoky, László; Géczi, L.; Doleschall, Zoltán; Bodrogi, I.; Csuka, O.; Kásler, M.; Bak, M.

In: Anticancer Research, Vol. 24, No. 2 C, 03.2004, p. 1097-1104.

Research output: Contribution to journalArticle

@article{1ff5bd8e7ed442b1b2434ca9c7712e12,
title = "Expression and Prognostic Value of the Lung Resistance-related Protein (LRP) in Germ Cell Testicular Tumors",
abstract = "Background: Lung resistance-related protein (LRP) was first detected in a non-P-glycoprotein-mediated multidrug-resistant lung cancer cell line and has been shown to be the major human vault protein. The aim of this study was to evaluate the expression of LRP in germ cell testicular tumors (GCT) and to determine the correlation between LRP expression and the clinical outcome of these tumors. Patients and Methods: Seventy cases of primary testicular tumors were investigated. LRP protein was detected by immunohistochemistry and Western blotting methods. LRP mRNA was determined with RT-PCR. Patients' clinical parameters and tumor response to treatment were recorded. Results: With immunohistochemistry, LRP was detected in 29 (41{\%}) out of 70 primary testicular tumors. Twenty-two (63{\%}) out of 35 tumors expressed LRP mRNA and LRP protein on examination by RT-PCR and Western blotting, respectively. Pure teratomas showed significantly higher LRP expression compared to other types of GCTs (p=0.0418). No relationship was demonstrated between the LRP immunostaining and stage of disease (p=0.2263). A significantly higher proportion of patients with LRP-negative tumors achieved complete response than those with LRP-positive tumors (p=0.0155). Patients whose tumors showed expression of LRP had significantly shorter overall survival (p=0.0428) than LRP-negative patients. Conclusion: Immunohistochemistry is a reliable method to evaluate LRP expression in testicular germ cell tumors. A positive correlation was found between LRP immunostaining and pure teratomas. LRP expression was associated with an adverse clinical outcome and shorter overall survival. Our findings suggest that LRP has prognostic value in testicular germ cell tumors and can predict clinical outcome.",
keywords = "Lung resistance-related protein, Testicular germ cell tumor",
author = "L{\'a}szl{\'o} M{\'a}ndoky and L. G{\'e}czi and Zolt{\'a}n Doleschall and I. Bodrogi and O. Csuka and M. K{\'a}sler and M. Bak",
year = "2004",
month = "3",
language = "English",
volume = "24",
pages = "1097--1104",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2 C",

}

TY - JOUR

T1 - Expression and Prognostic Value of the Lung Resistance-related Protein (LRP) in Germ Cell Testicular Tumors

AU - Mándoky, László

AU - Géczi, L.

AU - Doleschall, Zoltán

AU - Bodrogi, I.

AU - Csuka, O.

AU - Kásler, M.

AU - Bak, M.

PY - 2004/3

Y1 - 2004/3

N2 - Background: Lung resistance-related protein (LRP) was first detected in a non-P-glycoprotein-mediated multidrug-resistant lung cancer cell line and has been shown to be the major human vault protein. The aim of this study was to evaluate the expression of LRP in germ cell testicular tumors (GCT) and to determine the correlation between LRP expression and the clinical outcome of these tumors. Patients and Methods: Seventy cases of primary testicular tumors were investigated. LRP protein was detected by immunohistochemistry and Western blotting methods. LRP mRNA was determined with RT-PCR. Patients' clinical parameters and tumor response to treatment were recorded. Results: With immunohistochemistry, LRP was detected in 29 (41%) out of 70 primary testicular tumors. Twenty-two (63%) out of 35 tumors expressed LRP mRNA and LRP protein on examination by RT-PCR and Western blotting, respectively. Pure teratomas showed significantly higher LRP expression compared to other types of GCTs (p=0.0418). No relationship was demonstrated between the LRP immunostaining and stage of disease (p=0.2263). A significantly higher proportion of patients with LRP-negative tumors achieved complete response than those with LRP-positive tumors (p=0.0155). Patients whose tumors showed expression of LRP had significantly shorter overall survival (p=0.0428) than LRP-negative patients. Conclusion: Immunohistochemistry is a reliable method to evaluate LRP expression in testicular germ cell tumors. A positive correlation was found between LRP immunostaining and pure teratomas. LRP expression was associated with an adverse clinical outcome and shorter overall survival. Our findings suggest that LRP has prognostic value in testicular germ cell tumors and can predict clinical outcome.

AB - Background: Lung resistance-related protein (LRP) was first detected in a non-P-glycoprotein-mediated multidrug-resistant lung cancer cell line and has been shown to be the major human vault protein. The aim of this study was to evaluate the expression of LRP in germ cell testicular tumors (GCT) and to determine the correlation between LRP expression and the clinical outcome of these tumors. Patients and Methods: Seventy cases of primary testicular tumors were investigated. LRP protein was detected by immunohistochemistry and Western blotting methods. LRP mRNA was determined with RT-PCR. Patients' clinical parameters and tumor response to treatment were recorded. Results: With immunohistochemistry, LRP was detected in 29 (41%) out of 70 primary testicular tumors. Twenty-two (63%) out of 35 tumors expressed LRP mRNA and LRP protein on examination by RT-PCR and Western blotting, respectively. Pure teratomas showed significantly higher LRP expression compared to other types of GCTs (p=0.0418). No relationship was demonstrated between the LRP immunostaining and stage of disease (p=0.2263). A significantly higher proportion of patients with LRP-negative tumors achieved complete response than those with LRP-positive tumors (p=0.0155). Patients whose tumors showed expression of LRP had significantly shorter overall survival (p=0.0428) than LRP-negative patients. Conclusion: Immunohistochemistry is a reliable method to evaluate LRP expression in testicular germ cell tumors. A positive correlation was found between LRP immunostaining and pure teratomas. LRP expression was associated with an adverse clinical outcome and shorter overall survival. Our findings suggest that LRP has prognostic value in testicular germ cell tumors and can predict clinical outcome.

KW - Lung resistance-related protein

KW - Testicular germ cell tumor

UR - http://www.scopus.com/inward/record.url?scp=2442484892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442484892&partnerID=8YFLogxK

M3 - Article

C2 - 15154630

AN - SCOPUS:2442484892

VL - 24

SP - 1097

EP - 1104

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2 C

ER -